The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography
Meir Gare, MD*,
Yosef S. Haviv, MD
,
Arie Ben-Yehuda, MD
,
Dvorah Rubinger, MD
,
Tali Bdolah-Abram, MA*,
Shmuel Fuchs, MD*,
Ora Gat, BSc
,
Mordecai M. Popovtzer, MD
,
Mervyn S. Gotsman, MD, FACC* and
Morris Mosseri, MD*
* Cardiology Department, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Internal Medicine Division, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Nephrology and Hypertension Services, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Pharmacy Division, Hadassah Hebrew University Medical Center, Jerusalem, Israel

View larger version (17K):
[in a new window]
|
Figure 1 Cr (1, before; 2, after angiography) in the Control and Dopamine groups were similar (11.7 ± 4.9 and 19.2 ± 6.0, respectively, p = NS).
|
|

View larger version (13K):
[in a new window]
|
Figure 2 In patients with peripheral vascular disease, Cr (1, before; 2, after angiography) was 2.4 ± 2.3 µmol/liter in the Control group and 30.0 ± 12.0 µmol/liter in the Dopamine group, p < 0.05.
|
|
Copyright © 1999 by the American College of Cardiology Foundation.